← Open Payments lookup

NICHOLAS LEMMING: Open Payments

NPI 1427033562 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$876 in 42 payments from 12 companies in 2025. Trend: 2023 $1,006 · 2024 $1,044 · 2025 $876

Food & beverage: $838Education: $38
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$191
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$151
GlaxoSmithKline, LLC.6$115
ABBVIE INC.5$104
Boehringer Ingelheim Pharmaceuticals, Inc.5$95
Novo Nordisk Inc5$79
Lilly USA, LLC3$44
Neurocrine BioSciences, Inc.1$26
Abbott Laboratories1$20
PFIZER INC.1$19

Products named: CAPLYTA, TRELEGY ELLIPTA, FARXIGA, JARDIANCE, VRAYLAR, Wegovy, BREZTRI, BEVESPI AEROSPHERE.

Industry payments across IN — which companies pay providers there.